Simulating non-small cell lung cancer with a multiscale agent-based model
暂无分享,去创建一个
[1] Andrei Zinovyev,et al. [Systems biology of cancer]. , 2009, Medecine sciences : M/S.
[2] Daniel A. Haber,et al. Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.
[3] P. Bastiaens,et al. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.
[4] Sean Martin,et al. Advancing Cancer Systems Biology: Introducing the Center for the Development of a Virtual Tumor, CViT , 2007, Cancer informatics.
[5] T. Deisboeck,et al. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. , 2006, Journal of theoretical biology.
[6] G J Griffiths,et al. Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib. , 2006, Systems biology.
[7] T. Mok,et al. Apoptosis induced by troglitazone is both peroxisome proliferator‐activated receptor‐γ‐ and ERK‐dependent in human non‐small lung cancer cells , 2006, Journal of cellular physiology.
[8] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[9] Mike Holcombe,et al. An integrated agent-mathematical model of the effect of intercellular signalling via the epidermal growth factor receptor on cell proliferation. , 2006, Journal of theoretical biology.
[10] Barbara Di Ventura,et al. From in vivo to in silico biology and back , 2006, Nature.
[11] B. Zhivotovsky,et al. Inhibitors of the PI3‐kinase/Akt pathway induce mitotic catastrophe in non‐small cell lung cancer cells , 2006, International journal of cancer.
[12] M. Hendrix,et al. Influence of the microenvironment on melanoma cell fate determination and phenotype. , 2006, Cancer research.
[13] Stephanie Forrest,et al. Modeling Somatic Evolution in Tumorigenesis , 2006, PLoS Comput. Biol..
[14] S. McDougall,et al. Mathematical modeling of tumor-induced angiogenesis. , 2006, Annual review of biomedical engineering.
[15] G. Christofori. New signals from the invasive front , 2006, Nature.
[16] A. Chinnaiyan,et al. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. , 2006, Cancer research.
[17] L. Griffith,et al. Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.
[18] Thomas S Deisboeck,et al. The effects of EGF-receptor density on multiscale tumor growth patterns. , 2005, Journal of theoretical biology.
[19] A. Chinnaiyan,et al. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. , 2006, Cancer research.
[20] Jeffrey Wyckoff,et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.
[21] G. Silvestri,et al. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. , 2005, Chest.
[22] Ara A Vaporciyan,et al. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. , 2005, Radiology.
[23] Manuel Hidalgo,et al. Intracellular signal transduction pathway proteins as targets for cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Iyengar,et al. Toward predictive models of mammalian cells. , 2005, Annual review of biophysics and biomolecular structure.
[25] V. Boddi,et al. Correlation of Epidermal Growth Factor Receptor Expression with Tumor Microdensity Vessels and with Vascular Endothelial Growth Factor Expression in Ovarian Carcinoma , 2005, International journal of surgical pathology.
[26] Douglas A Lauffenburger,et al. Ligand accumulation in autocrine cell cultures. , 2005, Biophysical journal.
[27] Shinya Kuroda,et al. Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.
[28] Erik Sahai,et al. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. , 2005, Trends in cell biology.
[29] John C. Doyle,et al. Surviving heat shock: control strategies for robustness and performance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Lauffenburger,et al. Parsing ERK Activation Reveals Quantitatively Equivalent Contributions from Epidermal Growth Factor Receptor and HER2 in Human Mammary Epithelial Cells* , 2005, Journal of Biological Chemistry.
[31] Thomas S Deisboeck,et al. Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors. , 2004, Journal of theoretical biology.
[32] C. Nicholson,et al. Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. , 2004, Journal of neurophysiology.
[33] Eric W. Su,et al. Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer , 2004 .
[34] G. Stamp,et al. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. , 2004, Neoplasia.
[35] Francis Lin,et al. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. , 2004, Experimental cell research.
[36] R. Eils,et al. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.
[37] J. Condeelis,et al. Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation , 2004, The Journal of cell biology.
[38] P. Bunn,et al. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. , 2004, International journal of radiation oncology, biology, physics.
[39] S. Vicent,et al. Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients , 2004, Clinical Cancer Research.
[40] G. Tortora,et al. The role of EGFR inhibitors in nonsmall cell lung cancer , 2004, Current opinion in oncology.
[41] H. Othmer,et al. Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.
[42] Michael Lahn,et al. Expression levels of protein kinase C-alpha in non-small-cell lung cancer. , 2004, Clinical lung cancer.
[43] Amanda Y. Chan,et al. EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism , 2004, Clinical & Experimental Metastasis.
[44] D. Lauffenburger,et al. Self-organization of polarized cell signaling via autocrine circuits: computational model analysis. , 2004, Biophysical journal.
[45] D. Mukhopadhyay,et al. Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration* , 2003, Journal of Biological Chemistry.
[46] Chan Zeng,et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Thomas S Deisboeck,et al. The impact of "search precision" in an agent-based tumor model. , 2003, Journal of theoretical biology.
[48] H. Wiley,et al. An integrated model of epidermal growth factor receptor trafficking and signal transduction. , 2003, Biophysical journal.
[49] S. Kimura,et al. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. , 2003, The Biochemical journal.
[50] F. Campbell,et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration , 2003, Journal of Cell Science.
[51] P. Friedl,et al. Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.
[52] Fengqin Gao,et al. A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis* , 2003, The Journal of Biological Chemistry.
[53] Thomas S Deisboeck,et al. Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. , 2002, Journal of theoretical biology.
[54] Stefano Iacobelli,et al. The mechanism involved in the regulation of phospholipase Cγ1 activity in cell migration , 2002, Oncogene.
[55] J. Brognard,et al. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants , 2002, Cell Death and Differentiation.
[56] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[57] E. Gilles,et al. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.
[58] J. Minna,et al. Molecular pathogenesis of lung cancer. , 1994, Annual review of physiology.
[59] J. Brognard,et al. Brognard J, Dennis PVariable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants. Cell Death Differ 9: 893-904 , 2002 .
[60] D A Lauffenburger,et al. Spatial range of autocrine signaling: modeling and computational analysis. , 2001, Biophysical journal.
[61] S. Torquato,et al. Pattern of self‐organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model , 2001, Cell proliferation.
[62] R. Iyengar,et al. Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.
[63] C. Dang,et al. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Fell,et al. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.
[65] B. Kholodenko,et al. Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.
[66] A. Ullrich,et al. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. , 1999, Current opinion in cell biology.
[67] U. Bhalla,et al. Emergent properties of networks of biological signaling pathways. , 1999, Science.
[68] E. Dmitrovsky,et al. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[69] K. Fang,et al. An enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell line. , 1996, British Journal of Cancer.
[70] N. Haites,et al. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. , 1996, European journal of cancer.
[71] L. Ellis,et al. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[72] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[73] E. Dmitrovsky,et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. , 1993, Cancer research.
[74] A. Gazdar,et al. Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancer , 1992 .
[75] J. Roth,et al. Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer. , 1992, Surgical oncology.
[76] M. Inoue,et al. in Vitro Ovarian Cancer Cell Line Growth Factor Receptor Autocrine Growth Mechanism in an / Epidermal α Involvement of Transforming Growth Factor , 2006 .
[77] H. Kurachi,et al. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. , 1991, Cancer research.
[78] J. Freyer,et al. Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. , 1986, Cancer research.